Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Head and Neck Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 75 articles: HTML format Text format

Single Articles

May 2012
1. NGUYEN NP , Vos P, Vinh-Hung V, Ceizyk M, et al
   Feasibility of image-guided radiotherapy based on helical tomotherapy to reduce contralateral parotid dose in head and neck cancer.
   BMC Cancer. 2012;12:175.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. ZHOU Z , Sturgis EM, Liu Z, Wang LE, et al
   Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck.
   BMC Cancer. 2012;12:159.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
3. BLANCHARD P , Quero L, Schlageter MH, Pacault V, et al
   Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
   BMC Cancer. 2012;12:119.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. HO FC , Tham IW, Earnest A, Lee KM, et al
   Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: A meta-analysis of clinical evidence.
   BMC Cancer. 2012;12:98.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHI GZ , Yuan Y, Jiang GJ, Ge ZJ, et al
   PRAF3 induces apoptosis and inhibits migration and invasion in human esophageal squamous cell carcinoma.
   BMC Cancer. 2012;12:97.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
6. ZIELINSKI V , Brunner M, Heiduschka G, Schneider S, et al
   ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study.
   BMC Cancer. 2012;12:76.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. ACUNA SANHUEZA G , Faller L, George B, Koffler J, et al
   Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells.
   BMC Cancer. 2012;12:72.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SGOURAKIS G , Gockel I, Karaliotas C, Moehler M, et al
   Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study.
   BMC Cancer. 2012;12:70.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. SUN Y , Tang L, Chen L, Li W, et al
   Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
   BMC Cancer. 2012;12:68.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. JANG NY , Lee KW, Ahn SH, Kim JS, et al
    Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers.
    BMC Cancer. 2012;12:59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. CHIOFALO MG , Losito NS, Fulciniti F, Setola SV, et al
    Axillary node metastasis from differentiated thyroid carcinoma with hurthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings.
    BMC Cancer. 2012;12:55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
12. COUPLAND VH , Allum W, Blazeby JM, Mendall MA, et al
    Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.
    BMC Cancer. 2012;12:11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
13. RETEL VP , van der Molen L, Hilgers FJ, Rasch CR, et al
    A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
    BMC Cancer. 2011;11:475.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. DERBEL O , Limem S, Segura-Ferlay C, Lifante JC, et al
    Results of combined treatment of anaplastic thyroid carcinoma (ATC).
    BMC Cancer. 2011;11:469.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
15. MOORE SP , Green AC, Garvey G, Coory MD, et al
    A study of head and neck cancer treatment and survival among Indigenous and non-Indigenous people in Queensland, Australia, 1998 to 2004.
    BMC Cancer. 2011;11:460.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. REIS PP , Waldron L, Perez-Ordonez B, Pintilie M, et al
    A gene signature in histologically normal surgical margins is predictive of oral carcinoma recurrence.
    BMC Cancer. 2011;11:437.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. BALDINI E , Arlot-Bonnemains Y, Sorrenti S, Mian C, et al
    Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.
    BMC Cancer. 2011;11:411.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. PICKHARD AC , Margraf J, Knopf A, Stark T, et al
    Inhibition of Radiation Induced Migration of Human Head and Neck Squamous Cell Carcinoma Cells by Blocking of EGF Receptor Pathways.
    BMC Cancer. 2011;11:388.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. HUANG O , Wu WL, Wang OC, You J, et al
    Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma.
    BMC Cancer. 2011;11:386.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. YUN T , Han JY, Lee JS, Choi HL, et al
    Phase II Study of Weekly Paclitaxel and Capecitabine in Patients with Metastatic or Recurrent Esophageal Squamous Cell Carcinoma.
    BMC Cancer. 2011;11:385.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
21. CAO X , He LR, Xie FY, Chen YF, et al
    Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?
    BMC Cancer. 2011;11:370.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. BROSE MS , Nutting CM, Sherman SI, Shong YK, et al
    Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroi
    BMC Cancer. 2011;11:349.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. CHOI MH , Moon JY, Cho SH, Chung BC, et al
    Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma.
    BMC Cancer. 2011;11:342.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. JOHANSSON M , Ryden A, Finizia C
    Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - A longitudinal study.
    BMC Cancer. 2011;11:283.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. MA H , Wang LE, Liu Z, Sturgis EM, et al
    Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck.
    BMC Cancer. 2011;11:258.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
26. BASHASH M , Hislop TG, Shah AM, Le N, et al
    The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada.
    BMC Cancer. 2011;11:164.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
27. LEUNG SW , Lee TF, Chien CY, Chao PJ, et al
    Health-related Quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
    BMC Cancer. 2011;11:128.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
28. LU C , Xie H, Wang F, Shen H, et al
    Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2011;11:91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
29. MENG W , Xia Q, Wu L, Chen S, et al
    Downregulation of TGF-beta Receptor Types II and III in Oral Squamous Cell Carcinoma and Oral Carcinoma-Associated Fibroblasts.
    BMC Cancer. 2011;11:88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. XIE F , Liu H, Zhu YH, Qin YR, et al
    Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.
    BMC Cancer. 2011;11:86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. YUAN Y , Zeng ZY, Liu XH, Gong DJ, et al
    MicroRNA-203 inhibits cell proliferation by repressing DeltaNp63 expression in human esophageal squamous cell carcinoma.
    BMC Cancer. 2011;11:57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. JIANG M , Liu Z, Xiang Y, Ma H, et al
    Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    BMC Cancer. 2011;11:54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
33. PATRON V , Bedfert C, Le Clech G, Aubry K, et al
    Pattern of lateral neck metastases in N0 papillary thyroid carcinoma.
    BMC Cancer. 2011;11:8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. LI LW , Li YY, Li XY, Zhang CP, et al
    A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.
    BMC Cancer. 2011;11:52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. HSIEH CH , Kuo YS, Liao LJ, Hu KY, et al
    Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer.
    BMC Cancer. 2011;11:37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. LATINI FR , Hemerly JP, Freitas BC, Oler G, et al
    ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.
    BMC Cancer. 2011;11:11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. ANDOLFO I , Petrosino G, Vecchione L, De Antonellis P, et al
    Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma.
    BMC Cancer. 2011;11:126.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. HUBER GF , Zullig L, Soltermann A, Roessle M, et al
    Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx.
    BMC Cancer. 2011;11:217:1-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. JENSEN AD , Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, et al
    Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12).
    BMC Cancer. 2011;11:190.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. BOONSTRA JJ , Kok TC, Wijnhoven BP, van Heijl M, et al
    Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial.
    BMC Cancer. 2011;11:181.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. RADEMAKERS SE , Lok J, van der Kogel AJ, Bussink J, et al
    Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    BMC Cancer. 2011;11:167.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KUKWA W , Wojtowicz P, Jagielska B, Sobczyk G, et al
    Laryngeal embryonal rhabdomyosarcoma in an adult - a case presentation in the eyes of geneticists and clinicians.
    BMC Cancer. 2011;11:166.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. JENSEN AD , Krauss J, Potthoff K, Desta A, et al
    Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-
    BMC Cancer. 2011;11:182.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. YOON HH , Catalano PJ, Murphy KM, Skaar TC, et al
    Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.
    BMC Cancer. 2011;11:176.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. LORENZEN S , von Gall C, Stange A, Haag GM, et al
    Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
    BMC Cancer. 2011;11:266.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. POH CF , Durham JS, Brasher PM, Anderson DW, et al
    Canadian Optically-guided approach for Oral Lesions Surgical (COOLS) trial: study protocol for a randomized controlled trial.
    BMC Cancer. 2011;11:462.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. CASTAGNOLA P , Malacarne D, Scaruffi P, Maffei M, et al
    Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: distinctive features for tongue.
    BMC Cancer. 2011;11:445.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. HURT CN , Nixon LS, Griffiths GO, Al-Mokhtar R, et al
    SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus.
    BMC Cancer. 2011;11:466.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. HJORTLAND GO , Meza-Zepeda LA, Beiske K, Ree AH, et al
    Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
    BMC Cancer. 2011;11:455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. BRIEZ N , Piessen G, Bonnetain F, Brigand C, et al
    Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial.
    BMC Cancer. 2011;11:310.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LUBER B , Deplazes J, Keller G, Walch A, et al
    Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
    BMC Cancer. 2011;11:509.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
52. MACHA MA , Matta A, Chauhan SS, Siu KW, et al
    14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells.
    BMC Cancer. 2010;10:655.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. HABL G , Jensen AD, Potthoff K, Uhl M, et al
    Treatment of locally advanced carcinomas of head and neck with intensity-modulated radiation therapy (IMRT) in combination with cetuximab and chemotherapy: the REACH protocol.
    BMC Cancer. 2010;10:651.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. ZHANG D , Zhang Q, Zhou L, Huo L, et al
    Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.
    BMC Cancer. 2010;10:650.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. YANG X , Ren GX, Zhang CP, Zhou GY, et al
    Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.
    BMC Cancer. 2010;10:623.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. WANG S , Xiao X, Zhou X, Huang T, et al
    TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    BMC Cancer. 2010;10:617.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
57. TANG K , Li Y, Zhang Z, Gu Y, et al
    The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
    BMC Cancer. 2010;10:575.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. CHEW MM , Gan SY, Khoo AS, Tan EL, et al
    Interleukins, Laminin and Epstein-Barr virus Latent Membrane Protein 1 (EBV LMP1) Promote Metastatic Phenotype in Nasopharyngeal Carcinoma.
    BMC Cancer. 2010;10:574.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ZHANG L , Zhao C, Ghimire B, Hong M, et al
    The Role of Concurrent Chemoradiotherapy in the Treatment of Locoregionally Advanced Nasopharyngeal Carcinoma among Endemic Population: A Meta- analysis of the Phase III Randomized Trials.
    BMC Cancer. 2010;10:558.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ZHANG Y , Hu CF, Chen J, Yan LX, et al
    LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis of the Patients.
    BMC Cancer. 2010;10:538.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
61. TOUGERON D , Hamidou H, Scotte M, Di Fiore F, et al
    Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes.
    BMC Cancer. 2010;10:510.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
62. MLADKOVA J , Sanda M, Matouskova E, Selicharova I, et al
    Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.
    BMC Cancer. 2010;10:449.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. FANG H , Shen L, Chen T, He J, et al
    Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer.
    BMC Cancer. 2010;10:421.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
64. RALHAN R , Cao J, Lim T, Macmillan C, et al
    EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis.
    BMC Cancer. 2010;10:331.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
65. ZENGEL P , Ramp D, Mack B, Zahler S, et al
    Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis.
    BMC Cancer. 2010;10:92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. LIU G , Zheng H, Zhang Z, Wu Z, et al
    Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.
    BMC Cancer. 2010;10:495.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. HILL A , Bergin P, Hanning F, Thompson P, et al
    Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
    BMC Cancer. 2010;10:451.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. GRUNDMANN O , Fillinger JL, Victory KR, Burd R, et al
    Restoration of radiation therapy-induced salivary gland dysfunction in mice by post therapy IGF-1 administration.
    BMC Cancer. 2010;10:417.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GARCIA-CARRACEDO D , Rodrigo JP, Astudillo A, Nieto CS, et al
    Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients.
    BMC Cancer. 2010;10:416.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. LIU X , Wang A, Lo Muzio L, Kolokythas A, et al
    Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.
    BMC Cancer. 2010;10:365.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. WANG Z , He W, Yang G, Wang J, et al
    Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.
    BMC Cancer. 2010;10:352.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. RAUSER S , Langer R, Tschernitz S, Gais P, et al
    High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.
    BMC Cancer. 2010;10:608.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. PALANICHAMY MG , Zhang YP
    Potential pitfalls in MitoChip detected tumor-specific somatic mutations: a call for caution when interpreting patient data.
    BMC Cancer. 2010;10:597.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. JENSEN AD , Nikoghosyan A, Windemuth-Kieselbach C, Debus J, et al
    Combined treatment of malignant salivary gland tumours with intensity-modulated radiation therapy (IMRT) and carbon ions: COSMIC.
    BMC Cancer. 2010;10:546.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LIU W , Wang YF, Zhou HW, Shi P, et al
    Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    BMC Cancer. 2010;10:685.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: